, Volume 68, Issue 9–10, pp 829–835 | Cite as

A Stability Indicating LC Method for Vardenafil HCl

  • D. V. Subba Rao
  • K. V. Surendranath
  • P. Radhakrishnanand
  • M. V. Suryanarayana
  • P. Raghuram
Full Short Communication


A simple, sensitive gradient RP-LC assay method has been developed for the quantitative determination of vardenafil HCl in bulk drug and in pharmaceutical dosage forms, used to treat erectile dysfunction. The developed method is also applicable for the related substances determination. Efficient chromatographic separation was achieved on a C18 stationary phase with simple mobile phase combination delivered in a gradient mode and quantification was carried out using ultraviolet detection at a flow rate of 1.0 mL min−1. In the developed LC method the resolution between vardenafil and its four potential impurities was found to be greater than 3.0. Regression analysis shows an r 2 value (correlation coefficient) greater than 0.99 for vardenafil and its four impurities. This method was capable of detecting all four impurities of vardenafil at a level of 0.009% with respect to test concentration of 1.0 mg mL−1 for a 10 μL injection volume. The method has shown good and consistent recoveries for vardenafil (98.4–100.6%) and its four impurities (93.5–106.2%). The test solution was found to be stable in the diluent for 48 h. Mass balance was found close to 99.4%.


Column liquid chromatography Stability indicating study Vardenafil HCl 


  1. 1.
    USP DI (2005) Drug Information for the Health Care Professional, 25th edn. The United States Pharmacopeial Convention Inc., Rockville, MD, sildenafil (systemic) monographGoogle Scholar
  2. 2.
    Mosby’s Drug Consult (2005) 15th edn. Elsevier Inc., sildenafil monographGoogle Scholar
  3. 3.
    Wespes E, Amar E, Hatzichristou D, Montorsi F, Pryor J, Vardi Y (2002) Eur Urol 41:1–5. doi: 10.1016/S0302-2838(01)00008-2 CrossRefGoogle Scholar
  4. 4.
    Stief CG, Uckert S, Becker AJ, Truss MC, Jonas U (1998) J Urol 159:1390–1396. doi: 10.1016/S0022-5347(01)63622-X CrossRefGoogle Scholar
  5. 5.
    Bayot J (2005) Int Herald Tribune, p 15Google Scholar
  6. 6.
    Reepmeyer JC, Woodruff JT (2006) J Chromatogr A 1125:67–75. doi: 10.1016/j.chroma.2006.05.018 CrossRefGoogle Scholar
  7. 7.
    Zou P, Oh SS-Y, Hou P, Low M-Y, Koh H-L (2006) J Chromatogr A 1104:113–122. doi: 10.1016/j.chroma.2005.11.103 CrossRefGoogle Scholar
  8. 8.
    Zhu X, Xiao S, Chen B, Zhang F, Yao S, Wan Z et al (2005) J Chromatogr A 1066:89–95. doi: 10.1016/j.chroma.2005.01.038 CrossRefGoogle Scholar
  9. 9.
    Rodríguez Flores J, Berzas Nevado JJ, Castañeda Peñalvo G, Mora Diez N (2004) J Chromatogr B Analyt Technol Biomed Life Sci 811:231–236Google Scholar
  10. 10.
    Gratz SR, Flurer CL, Wolnik KA (2004) J Pharm Biomed Anal 36:525–533. doi: 10.1016/j.jpba.2004.07.004 CrossRefGoogle Scholar
  11. 11.
    Stability ICH Testing of New Drug Substances and Products Q1A (R2) (2003) International Conference on Harmonization, IFPMA, GenevaGoogle Scholar
  12. 12.
    Singh S, Bakshi M (2000) Pharm Tech On-line 24:1–14Google Scholar
  13. 13.
    ICH Photo stability Testing of New Drug Substances and ProductsQ1B, International Conference on Harmonization, IFPMA, Geneva (1996)Google Scholar
  14. 14.
    Bakshi M, Singh S (2002) J Pharm Biomed Anal 28:1011–1040. doi: 10.1016/S0731-7085(02)00047-X CrossRefGoogle Scholar
  15. 15.
    Singh S, Singh B, Bahuguna R, Wadhwa L, Saxena R (2006) J Pharm Biomed Anal 41:1037–1040. doi: 10.1016/j.jpba.2006.01.030 CrossRefGoogle Scholar
  16. 16.
    Drug stability principles and practices (2000) 3rd edn. Edited by Carstensen T, Rhodes CTGoogle Scholar
  17. 17.
    Validation of compendial methods (2008) The United States Pharmacopeia, 31st edn. USP31Google Scholar
  18. 18.
    ICH Validation of analytical procuderes: Text and methodology Q2 (R1), International Conference on Harmonization, IFPMA, Geneva (2005)Google Scholar

Copyright information

© Vieweg+Teubner | GWV Fachverlage GmbH 2008

Authors and Affiliations

  • D. V. Subba Rao
    • 1
  • K. V. Surendranath
    • 1
  • P. Radhakrishnanand
    • 1
  • M. V. Suryanarayana
    • 2
  • P. Raghuram
    • 3
  1. 1.United States Pharmacopeia-India Private Limited, Reference Standard LaboratoryHyderabadIndia
  2. 2.Dr. Reddy’s Laboratories LimitedHyderabadIndia
  3. 3.Hetero Labs LtdHyderabadIndia

Personalised recommendations